Cargando…
Prognostic and clinicopathological importance of microRNA-140 expression in cancer patients: a meta-analysis
BACKGROUND: MicroRNA-140 (miR-140) is one of the most widely investigated miRNAs in cell carcinogenesis and cancer development. Despite present proposals of employing miR-140 as a candidate biomarker for cancer prognosis, its effectiveness in predicting patient survival and clinicopathological outco...
Autores principales: | Zheng, Mengxia, Liu, Jingting, Meng, Chunyan, Tang, Kaifeng, Liao, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417971/ https://www.ncbi.nlm.nih.gov/pubmed/34479600 http://dx.doi.org/10.1186/s12957-021-02380-6 |
Ejemplares similares
-
Prognostic and clinicopathological significance of CD155 expression in cancer patients: a meta-analysis
por: Zhang, Dan, et al.
Publicado: (2022) -
Deleted in Breast Cancer 1 as a Novel Prognostic Biomarker for Digestive System Cancers: A Meta-Analysis
por: Liu, Jingting, et al.
Publicado: (2019) -
Implication of microRNA-140 in osteoarthritis
por: Martel-Pelletier, Johanne
Publicado: (2012) -
TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis
por: Meng, Chunyan, et al.
Publicado: (2018) -
Prognostic Value and Clinicopathological Features of MicroRNA-206 in Various Cancers: A Meta-Analysis
por: Liu, Rongqiang, et al.
Publicado: (2020)